Melbourne, Dec 8, 2008 (ABN Newswire) - Starpharma Holdings Ltd (ASX:SPL)(OTCQX:SPHRY) recently announced the Company’s most important commercial milestone to date with the signing of a full license agreement with SSL International for the development of the VivaGel(R)-coated condom. SSL manufactures and markets Durex(R), the world’s number one condom.
